Immuno Concepts specializes in the development of advanced diagnostic assays aimed at identifying systemic rheumatic diseases. A key innovation from the company is the HEp-2000® substrate, which has been genetically enhanced to improve sensitivity in detecting autoantibodies, particularly those related to SS-A/Ro. This advancement has addressed significant challenges in the detection of anti-nuclear antibodies (ANAs) by transitioning from traditional rodent tissue to HEp-2 cells, thereby enhancing the accuracy and reliability of diagnostic testing. The clinical efficacy of HEp-2000® has been validated through over thirty publications, underscoring its superior performance in the field.

In addition to the HEp-2000® substrate, Immuno Concepts offers a range of immunofluorescent test systems, including the Colorzyme® and RELISA® Test Systems, which are designed to facilitate the detection of various autoantibodies. The Image Navigator® Automated Microscope further enhances the testing process by providing automated imaging capabilities, streamlining the workflow for laboratories. The company also provides quality control solutions, such as the FITC-QC Slide Pattern Controls, ensuring the reliability of test results. Overall, Immuno Concepts is committed to advancing diagnostic technologies that improve patient outcomes in rheumatic disease management.

United States

Quality is our Heritage - Service is our Passion
Immuno Concepts is a privately hold company that specialises in the manufacturing of in vitro diagnostics for Autoimmune Diseases since 1980.
Our product portfolio comprises reagents and instrumentation such as a unique automatic microscope scanning system for immunofluorescent slide tests.
Hospital labs all over the globe and major lab chains trust in our quality and service.

Immuno Concepts

Company Details